In Vivo Delivery of RNAi with Lipid-Based Nanoparticles

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.

Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256

The nuclear RNase III Drosha initiates microRNA processing

Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,299

Role for a bidentate ribonuclease in the initiation step of RNA interference

Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 5,018

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954

A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,295

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115

Mechanisms of gene silencing by double-stranded RNA

Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,598

MicroRNA maturation: stepwise processing and subcellular localization

Lee, Y., Jeon, K., Lee, J., Kim, S., & Kim, V. N. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf476 · Cited by 2,572

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D. B., Tolcher, A. W., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,541

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438

Expression profiling reveals off-target gene regulation by RNAi

Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370

Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing

Grishok, A., Pasquinelli, A. E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D. L., Fire, A., Ruvkun, G., & Mello, C. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00431-7 · Cited by 1,908

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677

Pharmacokinetics and Biodistribution of Nanoparticles

Li, S., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,603

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cellsPreprint

Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,571

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

Kota, J., Chivukula, R. R., O'Donnell, K. A., Wentzel, E. A., Montgomery, C. L., Hwang, H.-W., Chang, T.-C., Vivekanandan, P., Torbenson, M., Clark, K. R., et al. (2009) · Cell · doi:10.1016/j.cell.2009.04.021 · Cited by 1,452

Activation of the interferon system by short-interfering RNAs

Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,401

Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis

Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,339

Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7

Hornung, V., Guenthner‐Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A. M., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,261

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,260

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,228

Interfering with disease: a progress report on siRNA-based therapeutics

de Fougerolles, A., Vornlocher, H., Maraganore, J. M., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,223

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K. S., Jensen, K., Breen, W., Hartsough, K. C., Machemer, L., Radka, S. F., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,175

Distinct endocytic pathways regulate TGF-β receptor signalling and turnover

Guglielmo, G. M. D., Roy, C. L., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,152

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150

Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,

Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,136

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129

Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes

Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,083

Strategies for silencing human disease using RNA interference

Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078

RNA interference in adult mice

McCaffrey, A. P., Meuse, L., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,061

Lipid-like materials for low-dose, in vivo gene silencing

Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969

3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets

Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

Bartlett, D. W., Su, H. C., Hildebrandt, I. J., Weber, W., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 820

Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing

Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J. M., Guo, J., Johnson, J. M., Lim, L. P., Karpilow, J. M., Nichols, K. E., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 804

siRNA vs. shRNA: Similarities and differences

Rao, D. D., Vorhies, J. S., Senzer, N. N., & Nemunaitis, J. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 702

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Frank-Kamenetsky, M. D., Grefhorst, A., Anderson, N. N., Racie, T., Bramlage, B., Akinc, A., Butler, D., Charissé, K., Dorkin, J. R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 645

Second-generation shRNA libraries covering the mouse and human genomes

Silva, J. M., Li, M. Z., Chang, K. C. N., Ge, W., Golding, M. C., Rickles, R. J., Siolas, D., Hu, G., Paddison, P. J., Schlabach, M. R., et al. (2005) · Nature Genetics · doi:10.1038/ng1650 · Cited by 625

Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi

McBride, J. L., Boudreau, R. L., Harper, S. Q., Staber, P. D., Mas, A., Martins, I., Gilmore, B. L., Burstein, H., PELUSO, R. W., Polisky, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801775105 · Cited by 616

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

Bartlett, D. W. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj439 · Cited by 601

On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

Hafez, I., Maurer, N., & Cullis, P. R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601

Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting

Li, S., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 569

Effects of cloud-point grafting, chain length, and density of PEG layers on competitive adsorption of ocular proteins

Kingshott, P., Thissen, H. W., & Griesser, H. J. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00334-9 · Cited by 538

Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy

Chen, Y., Zhu, X., Zhang, X., Liu, B., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.136 · Cited by 516

The role of complement in inflammation and phagocytosis

Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 505

Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells

Thomas, M., & Klibanov, A. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192581499 · Cited by 494

Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer

Li, S., & Huang, L. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.06.022 · Cited by 487

Lipid-based systemic delivery of siRNA

Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 468

Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery

Li, J., Chen, Y.-C., Tseng, Y. C., Mozumdar, S., & Huang, L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.008 · Cited by 467

Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 3

Karikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446

Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol)

Kenworthy, A. K., Hristova, K. A., Needham, D., & McIntosh, T. J. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80369-3 · Cited by 408

Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid

Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 400

Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo

Bertrand, J., Pottier, M., Vekris, A., Opolon, P., Maksimenko, A., & Malvy, C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02013-2 · Cited by 400

PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner

Ishida, T., Wang, X., Shimizu, T., Nawata, K., & Kiwada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.015 · Cited by 382

Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo

Mori, A., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80699-4 · Cited by 369

Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats

Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 368

Chemical modification of siRNAs to improve serum stability without loss of efficacy

Choung, S., Kim, Y., Kim, S., Park, H.-O., & Choi, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348

Toward Synthetic Viruses: Endosomal pH-Triggered Deshielding of Targeted Polyplexes Greatly Enhances Gene Transfer in vitro and in vivo

Walker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 326

Delivery of Molecular Medicine to Solid Tumors

Jain, R. K. (1996) · Science · doi:10.1126/science.271.5252.1079 · Cited by 312

Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice

Ishida, O., Maruyama, K., Sasaki, K., & Iwatsuru, M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00256-2 · Cited by 309

A status report on RNAi therapeutics

Vaishnaw, A. K., Gollob, J., Gamba‐Vitalo, C., Hutabarat, R. M., Sah, D. W. Y., Meyers, R. E., de Fougerolles, T., & Maraganore, J. M. (2010) · Silence · doi:10.1186/1758-907x-1-14 · Cited by 305

Stabilized plasmid-lipid particles: construction and characterization

Wheeler, J. J., Palmer, L., Ossanlou, M., MacLachlan, I., Graham, R. W., Zhang, Y. P., Hope, M. J., Scherrer, P., & Cullis, P. R. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300821 · Cited by 301

Lipid Polymorphism:The Molecular Basis of Nonbilayer Phases

Gruner, S. M., Cullis, P. R., Hope, M. J., & Tilcock, C. (1985) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.14.060185.001235 · Cited by 296

Hypersensitivity and Loss of Disease Site Targeting Caused by Antibody Responses to PEGylated Liposomes

Judge, A. D., McClintock, K., Phelps, J. R., & MacLachlan, I. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280

Roles of lipid polymorphism in intracellular delivery

Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 275

The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation

Taulli, R., Bersani, F., Foglizzo, V., Linari, A., Vigna, E., Ladanyi, M., Tuschl, T., & Ponzetto, C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38075 · Cited by 260

Biodistribution of phosphodiester and phosphorothioate siRNA

Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251

Misinterpreting the Therapeutic Effects of Small Interfering RNA Caused by Immune Stimulation

Robbins, M., Judge, A. D., Ambegia, E., Choi, C., Yaworski, E., Palmer, L., McClintock, K., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.131 · Cited by 247

Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes

Woodle, M. C., Matthay, K. K., Newman, M. S., Hidayat, J., Collins, L. R., Redemann, C. T., Martin, F. J., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90194-q · Cited by 241

Steric Stabilization of Fusogenic Liposomes by a Low-pH Sensitive PEG−Diortho Ester−Lipid Conjugate

Guo, X. D., & Szoka, F. C. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000110v · Cited by 233

Lipid membranes with grafted polymers: physicochemical aspects

Marsh, D., Bartucci, R., & Sportelli, L. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00197-4 · Cited by 232

Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?

Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227

Poly(ethylene glycol)−Lipid Conjugates Regulate the Calcium-Induced Fusion of Liposomes Composed of Phosphatidylethanolamine and Phosphatidylserine

Holland, J. W., Hui, C., Cullis, P. R., & Madden, T. D. (1996) · Biochemistry · doi:10.1021/bi952000v · Cited by 223

A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

Lu, J. J.-Q., Langer, R., & Chen, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900023v · Cited by 222

INTRAVENOUSLY ADMINISTERED SHORT INTERFERING RNA ACCUMULATES IN THE KIDNEY AND SELECTIVELY SUPPRESSES GENE FUNCTION IN RENAL PROXIMAL TUBULES

van de Water, F. M., Boerman, O. C., Wouterse, A. C., Peters, J. G. P., Rüssel, F. G. M., & Masereeuw, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009555 · Cited by 221

Progress and prospects: nuclear import of nonviral vectors

Lam, A. P., & Dean, D. A. (2010) · Gene Therapy · doi:10.1038/gt.2010.31 · Cited by 211

Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid

Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211

Liposome-mediated DNA vaccination: the effect of vesicle composition

Perrie, Y., Frederik, P. M., & Gregoriadis, G. C. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00432-1 · Cited by 210

Cationic liposomal lipids: From gene carriers to cell signaling

Lonez, C., Vandenbranden, M., & Ruysschaert, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.03.002 · Cited by 208

New Detachable Poly(ethylene glycol) Conjugates: Cysteine-Cleavable Lipopolymers Regenerating Natural Phospholipid, Diacyl Phosphatidylethanolamine

Zalipsky, S., Qazen, M. M., Walker, J. A., Mullah, N. N., Quinn, Y. P., & Huang, S. K. (1999) · Bioconjugate Chemistry · doi:10.1021/bc990031n · Cited by 198

Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA

Li, S., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 195

Immunostimulation of dendritic cells by cationic liposomes

Vangasseri, D. P., Cui, Z., Chen, W., Hokey, D. A., Falo, L. D., & Huang, L. (2006) · Molecular Membrane Biology · doi:10.1080/09687860600790537 · Cited by 183

Mechanism of adjuvant activity of cationic liposome: Phosphorylation of a MAP kinase, ERK and induction of chemokines

Yan, W., Chen, W., & Huang, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.009 · Cited by 178

Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic

Wolff, J. A., & Rozema, D. B. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300326 · Cited by 165

Toxicogenomics of Non-viral Vectors for Gene Therapy: A Microarray Study of Lipofectin- and Oligofectamine-induced Gene Expression Changes in Human Epithelial Cells

Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152

Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs

Bragonzi, A., Dina, G., Villa, A., Calori, G., Biffi, A., Bordignon, C., Assael, B. M., & Conese, M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301282 · Cited by 151

MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity

Turner, J. J., Jones, S. W., Moschos, S. A., Lindsay, M. A., & Gait, M. J. (2006) · Molecular BioSystems · doi:10.1039/b611612d · Cited by 146

siRNA applications in nanomedicine

Tokatlian, T., & Segura, T. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.81 · Cited by 138

Accumulation of Liposomal Lipid and Encapsulated Doxorubicin in Murine Lewis Lung Carcinoma: The Lack of Beneficial Effects by Coating Liposomes with Poly(ethylene glycol)

Parr, M. J., Masin, D., Cullis, P. R., & Bally, M. B. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36521-8 · Cited by 126

Characteristics and biodistribution of cationic liposomes and their DNA complexes

Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H., & Kitagawa, T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00293-5 · Cited by 117

Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity

Hollins, A. J., Omidi, Y., Benter, I. F., & Akhtar, S. (2007) · Journal of drug targeting · doi:10.1080/10611860601151860 · Cited by 117

RNAi: RISC Gets Loaded

Preall, J. B., & Sontheimer, E. J. (2005) · Cell · doi:10.1016/j.cell.2005.11.006 · Cited by 114

Effects of Polyethyleneglycol Chain Length and Phospholipid Acyl Chain Composition on the Interaction of Polyethyleneglycol-phospholipid Conjugates with Phospholipid: Implications in Liposomal Drug Delivery

Bedu-Addo, F. K., Tang, P. S., Xu, Y., & Huang, L. (1996) · Pharmaceutical Research · doi:10.1023/a:1016091314940 · Cited by 105

Stabilization of bilayer structure for unsaturated phosphatidylethanolamines by detergents

Madden, T. D., & Cullis, P. R. (1982) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(82)90061-x · Cited by 103

Immunostimulation Mechanism of LPD Nanoparticle as a Vaccine Carrier

Cui, Z., Han, S., Vangasseri, D. P., & Huang, L. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049907k · Cited by 101

Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers

Zhang, J. X. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 95

Poly(ethylene glycol)−Lipid Conjugates Promote Bilayer Formation in Mixtures of Non-Bilayer-Forming Lipids

Holland, J. W., Cullis, P. R., & Madden, T. D. (1996) · Biochemistry · doi:10.1021/bi951999j · Cited by 90

Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production

Tagami, T., Nakamura, K., Shimizu, T., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.006 · Cited by 81

Stabilized Plasmid–Lipid Particles: Pharmacokinetics and Plasmid Delivery to Distal Tumors following Intravenous Injection

Monck, M. A., Mori, A., Lee, D., Tam, P., Wheeler, J. J., Cullis, P. R., & Scherrer, P. (2000) · Journal of drug targeting · doi:10.3109/10611860009102218 · Cited by 78

CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes

Tagami, T., Nakamura, K., Shimizu, T., Yamazaki, N., Ishida, T., & Kiwada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.017 · Cited by 77

[3] Stabilized plasmid-lipid particles: A systemic gene therapy vector

Fenske, D. B., MacLachlan, I., & Cullis, P. R. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46048-x · Cited by 72

Homing in on delivery

Baker, M. (2010) · Nature · doi:10.1038/4641225a · Cited by 62

Defective antigen processing correlates with a low level of intracellular glutathione

Short, S., Merkel, B. J., Caffrey, R., & McCoy, K. L. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261229 · Cited by 57

Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes

Shimada, K., Matsuo, S., Sadzuka, Y., Miyagishima, A., Nozawa, Y., Hirota, S., & Sonobe, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00466-x · Cited by 54

The effect of surface charges of liposomes in immunopotentiation

Latif, N. A., & Bachhawat, B. K. (1984) · Bioscience Reports · doi:10.1007/bf01120305 · Cited by 38

Lipid-Protamine-DNA-Mediated Antigen Delivery

Vangasseri, D., Han, S., & Huang, L. (2005) · Current Drug Delivery · doi:10.2174/156720105774370168 · Cited by 31

Synthetic vs. Natural/Biodegradable Polymers for Delivery of shRNA-Based Cancer Therapies

Vorhies, J. S., & Nemunaitis, J. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-429-2_2 · Cited by 26

Isolation of variants of chinese hamster ovary cells with abnormally low levels of GSH: Decreased ability to cleave endocytosed disulfide bonds

Mandel, R., Ryser, H. J. ‐., Niaki, B., Ghani, F., & Shen, W. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041490109 · Cited by 9

In Vivo siRNA Delivery to the Mouse Hypothalamus Shows a Role of the Co-Chaperone XAP2 in Regulating TRH Transcription

Decherf, S., Hassani, Z., & DEMENEIX, B. A. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-237-3_21 · Cited by 3

Delivery materials for siRNA therapeutics

Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800

Nanotechnology for Multimodal Synergistic Cancer Therapy

Fan, W., Yung, B. C., Huang, P., & Chen, X. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,813

Current Strategies for Brain Drug Delivery

Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954

Cancer nanomedicine for combination cancer immunotherapy

Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 955

The delivery of therapeutic oligonucleotides

Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 882

Lipid-based nanocarriers for RNA delivery

(2015) · TUScholarShare (Temple University) · doi:10.34944/dspace/5203

Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges

Zhou, J., Shum, K., Burnett, J., & Rossi, J. J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 211

Delivery of RNAi therapeutics: work in progress

Miller, A. D. (2013) · Expert Review of Medical Devices · doi:10.1586/17434440.2013.855471 · Cited by 34

Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach

Haghighi, E., Abolmaali, S. S., Dehshahri, A., Shaegh, S. A. M., Azarpira, N., & Tamaddon, A. M. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02972-w · Cited by 125

Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines

Liu, Z., Wang, S., Tapeinos, C., Torrieri, G., Känkänen, V., El‐Sayed, N., Python, A., Hirvonen, J. J., & Santos, H. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.018 · Cited by 73